Costs and Evaluation of Vital and Essential Medicines for Internal Diseases Treatment, Purchased by Medical Organizations with the Funding from the System of Obligatory Medical Insurance in 2017
Aim. To assess the cost and importance of the vital and essential medicines for the treatment of 12 groups of internal diseases purchased in 2017 by the «key» medical organizations in the subjects of Russian Federation with the funding from the system of compulsory medical insurance.Material and met...
Saved in:
| Main Authors: | O. M. Drapkina, A. V. Kontsevaya, M. V. Sura, R. N. Shepel, L. M. Zhamalov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2019-11-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2039 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PHARMACO-ECONOMICAL ASPECTS OF IN-PATIENT TREATMENT OF CHILDREN WITH PERINATAL
by: N.M. Sudakova, et al.
Published: (2012-02-01) -
The joint use of ABC/VEN analysis and the Beers criteria for optimizing expenditure of funds and rational prescribing of medications to elderly patients
by: O. A. Makhmudova, et al.
Published: (2025-02-01) -
Clinical and economic analysis of drug costs in a general hospital in 2014-2018
by: A. T. Burbello, et al.
Published: (2020-02-01) -
The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia
by: V. V. Omelyanovsky, et al.
Published: (2018-11-01) -
Potential cost savings from generic medicines – protecting the Prescribed Minimum Benefits
by: Elizabeth Nicolosi, et al.
Published: (2009-02-01)